BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 38299866)

  • 21. Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus.
    Endo Y; Igarashi T; Nishimura Y; Buckler C; Buckler-White A; Plishka R; Dimitrov DS; Martin MA
    J Virol; 2000 Aug; 74(15):6935-45. PubMed ID: 10888632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies.
    Gautam R; Nishimura Y; Lee WR; Donau O; Buckler-White A; Shingai M; Sadjadpour R; Schmidt SD; LaBranche CC; Keele BF; Montefiori D; Mascola JR; Martin MA
    J Virol; 2012 Aug; 86(16):8516-26. PubMed ID: 22647691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a simian human immunodeficiency virus encoding the envelope gene from the CCR5-tropic HIV-1 Ba-L.
    Pal R; Taylor B; Foulke JS; Woodward R; Merges M; Praschunus R; Gibson A; Reitz M
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):300-7. PubMed ID: 12843740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutralization-sensitive R5-tropic simian-human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infection.
    Siddappa NB; Song R; Kramer VG; Chenine AL; Velu V; Ong H; Rasmussen RA; Grisson RD; Wood C; Zhang H; Kankasa C; Amara RR; Else JG; Novembre FJ; Montefiori DC; Ruprecht RM
    J Virol; 2009 Feb; 83(3):1422-32. PubMed ID: 19019970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenic features associated with increased virulence upon Simian immunodeficiency virus cross-species transmission from natural hosts.
    Mandell DT; Kristoff J; Gaufin T; Gautam R; Ma D; Sandler N; Haret-Richter G; Xu C; Aamer H; Dufour J; Trichel A; Douek DC; Keele BF; Apetrei C; Pandrea I
    J Virol; 2014 Jun; 88(12):6778-92. PubMed ID: 24696477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional Perturbation of Mucosal Group 3 Innate Lymphoid and Natural Killer Cells in Simian-Human Immunodeficiency Virus/Simian Immunodeficiency Virus-Infected Infant Rhesus Macaques.
    Hueber B; Curtis AD; Kroll K; Varner V; Jones R; Pathak S; Lifton M; Van Rompay KKA; De Paris K; Reeves RK
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute Schistosoma mansoni infection increases susceptibility to systemic SHIV clade C infection in rhesus macaques after mucosal virus exposure.
    Chenine AL; Shai-Kobiler E; Steele LN; Ong H; Augostini P; Song R; Lee SJ; Autissier P; Ruprecht RM; Secor WE
    PLoS Negl Trop Dis; 2008 Jul; 2(7):e265. PubMed ID: 18648516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of lineage-related, mucosally transmissible subtype C R5 simian-human immunodeficiency viruses capable of AIDS development, induction of neurological disease, and coreceptor switching in rhesus macaques.
    Ren W; Mumbauer A; Gettie A; Seaman MS; Russell-Lodrigue K; Blanchard J; Westmoreland S; Cheng-Mayer C
    J Virol; 2013 Jun; 87(11):6137-49. PubMed ID: 23514895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of CD4 independence envelopes and astrocyte infection in R5 simian-human immunodeficiency virus model of encephalitis.
    Zhuang K; Leda AR; Tsai L; Knight H; Harbison C; Gettie A; Blanchard J; Westmoreland S; Cheng-Mayer C
    J Virol; 2014 Aug; 88(15):8407-20. PubMed ID: 24829360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses.
    Reimann KA; Watson A; Dailey PJ; Lin W; Lord CI; Steenbeke TD; Parker RA; Axthelm MK; Karlsson GB
    Virology; 1999 Mar; 256(1):15-21. PubMed ID: 10087222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-21 up-regulates interleukin-21R expression and interferon gamma production by CD8+ cells in SHIV-infected macaques.
    Zhao CC; Gao XQ; Xue J; Cong Z; Zhang WL; Chen T; Wu FX; Xiong J; Ju B; Su A; Wei Q; Qin C
    Exp Biol Med (Maywood); 2013 Apr; 238(4):400-9. PubMed ID: 23760006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosal transmissibility, disease induction and coreceptor switching of R5 SHIVSF162P3N molecular clones in rhesus macaques.
    Ren W; Mumbauer A; Zhuang K; Harbison C; Knight H; Westmoreland S; Gettie A; Blanchard J; Cheng-Mayer C
    Retrovirology; 2013 Jan; 10():9. PubMed ID: 23369442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early Env-specific CTLs effectively suppress viral replication in SHIV controller macaques.
    Fan J; Liang H; Shen T; Wang S; Ji X; Yee C; Lu F; Shao Y
    Cell Immunol; 2018 Sep; 331():30-37. PubMed ID: 29773224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simian-human immunodeficiency virus containing a human immunodeficiency virus type 1 subtype-E envelope gene: persistent infection, CD4(+) T-cell depletion, and mucosal membrane transmission in macaques.
    Himathongkham S; Halpin NS; Li J; Stout MW; Miller CJ; Luciw PA
    J Virol; 2000 Sep; 74(17):7851-60. PubMed ID: 10933692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced Simian Immunodeficiency Virus Replication in Macrophages of Sooty Mangabeys Is Associated with Increased Expression of Host Restriction Factors.
    Mir KD; Mavigner M; Wang C; Paiardini M; Sodora DL; Chahroudi AM; Bosinger SE; Silvestri G
    J Virol; 2015 Oct; 89(20):10136-44. PubMed ID: 26202248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenic consequences of vaginal infection with CCR5-tropic simian-human immunodeficiency virus SHIVSF162P3N.
    Shakirzyanova M; Tsai L; Ren W; Gettie A; Blanchard J; Cheng-Mayer C
    J Virol; 2012 Sep; 86(17):9432-42. PubMed ID: 22740397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The number and genetic relatedness of transmitted/founder virus impact clinical outcome in vaginal R5 SHIVSF162P3N infection.
    Tsai L; Tasovski I; Leda AR; Chin MP; Cheng-Mayer C
    Retrovirology; 2014 Mar; 11():22. PubMed ID: 24612462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adaptation of a transmitted/founder simian-human immunodeficiency virus for enhanced replication in rhesus macaques.
    Bauer A; Lindemuth E; Marino FE; Krause R; Joy J; Docken SS; Mallick S; McCormick K; Holt C; Georgiev I; Felber B; Keele BF; Veazey R; Davenport MP; Li H; Shaw GM; Bar KJ
    PLoS Pathog; 2023 Jul; 19(7):e1011059. PubMed ID: 37399208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses.
    Reimann KA; Parker RA; Seaman MS; Beaudry K; Beddall M; Peterson L; Williams KC; Veazey RS; Montefiori DC; Mascola JR; Nabel GJ; Letvin NL
    J Virol; 2005 Jul; 79(14):8878-85. PubMed ID: 15994781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virus-specific T cell responses in macaques acutely infected with SHIV(sf162p3).
    Pahar B; Wang X; Dufour J; Lackner AA; Veazey RS
    Virology; 2007 Jun; 363(1):36-47. PubMed ID: 17307212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.